State of Tennessee Treasury Department lifted its position in shares of Prestige Consumer Healthcare Inc (NYSE:PBH) by 26.3% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 79,184 shares of the company’s stock after buying an additional 16,470 shares during the period. State of Tennessee Treasury Department owned about 0.16% of Prestige Consumer Healthcare worth $2,904,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of PBH. Champlain Investment Partners LLC boosted its position in Prestige Consumer Healthcare by 3.7% during the first quarter. Champlain Investment Partners LLC now owns 2,462,320 shares of the company’s stock valued at $90,318,000 after purchasing an additional 86,915 shares during the last quarter. Macquarie Group Ltd. boosted its position in Prestige Consumer Healthcare by 14.4% during the fourth quarter. Macquarie Group Ltd. now owns 2,001,580 shares of the company’s stock valued at $81,065,000 after purchasing an additional 251,580 shares during the last quarter. State Street Corp boosted its position in Prestige Consumer Healthcare by 0.4% during the first quarter. State Street Corp now owns 1,784,780 shares of the company’s stock valued at $65,466,000 after purchasing an additional 6,744 shares during the last quarter. Acadian Asset Management LLC boosted its position in Prestige Consumer Healthcare by 5.0% during the first quarter. Acadian Asset Management LLC now owns 1,502,782 shares of the company’s stock valued at $55,125,000 after purchasing an additional 71,201 shares during the last quarter. Finally, Nuveen Asset Management LLC boosted its position in Prestige Consumer Healthcare by 18.9% during the first quarter. Nuveen Asset Management LLC now owns 1,346,190 shares of the company’s stock valued at $49,379,000 after purchasing an additional 213,939 shares during the last quarter.

In other news, CEO Ronald M. Lombardi sold 29,593 shares of the stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $40.00, for a total transaction of $1,183,720.00. Following the transaction, the chief executive officer now owns 154,630 shares in the company, valued at $6,185,200. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 1.14% of the stock is currently owned by company insiders.

Shares of NYSE PBH opened at $36.63 on Tuesday. The firm has a market cap of $1.85 billion, a P/E ratio of 13.18, a price-to-earnings-growth ratio of 3.08 and a beta of 0.80. The company has a current ratio of 2.44, a quick ratio of 1.67 and a debt-to-equity ratio of 1.50. Prestige Consumer Healthcare Inc has a 1-year low of $27.40 and a 1-year high of $46.12. The business’s 50 day moving average is $40.62 and its 200-day moving average is $39.60.

Prestige Consumer Healthcare (NYSE:PBH) last announced its earnings results on Thursday, May 7th. The company reported $0.82 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.74 by $0.08. The company had revenue of $251.20 million for the quarter, compared to analyst estimates of $239.65 million. Prestige Consumer Healthcare had a return on equity of 13.33% and a net margin of 14.77%. The firm’s quarterly revenue was up 4.2% compared to the same quarter last year. During the same quarter last year, the company earned $0.72 earnings per share. Analysts forecast that Prestige Consumer Healthcare Inc will post 2.99 EPS for the current year.

Several research analysts recently commented on the company. ValuEngine cut Prestige Consumer Healthcare from a “hold” rating to a “sell” rating in a research report on Friday, May 1st. BMO Capital Markets raised their price objective on Prestige Consumer Healthcare from $85.00 to $91.00 and gave the company a “market perform” rating in a research report on Tuesday, May 12th. CIBC raised their price objective on Prestige Consumer Healthcare from $86.00 to $88.00 and gave the company a “neutral” rating in a research report on Tuesday, May 12th. Jefferies Financial Group cut Prestige Consumer Healthcare from a “buy” rating to a “hold” rating in a research report on Tuesday, April 14th. Finally, TD Securities cut Prestige Consumer Healthcare to a “hold” rating and set a $86.00 price objective for the company. in a research report on Tuesday, April 14th. One research analyst has rated the stock with a sell rating, six have given a hold rating and two have issued a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of $63.29.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning.

See Also: What is a stock portfolio tracker?

Want to see what other hedge funds are holding PBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Prestige Consumer Healthcare Inc (NYSE:PBH).

Institutional Ownership by Quarter for Prestige Consumer Healthcare (NYSE:PBH)

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.